>
BioForce Nanosciences Holdings Inc logo

BFNH - BioForce Nanosciences Holdings Inc Share Price

$0.7 0.0  0.0%

Last Trade - 20/04/21

Sector
Consumer Cyclicals
Size
Micro Cap
Market Cap £14.7m
Enterprise Value £14.7m
Revenue £n/a
Position in Universe 6142nd / 6852
Bullish
Bearish
Unlock BFNH Revenue
Momentum
Relative Strength (%)
1m -27.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -65.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1.13 0.008 0.005 0.016 0.018 0.000 -100.0%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, BioForceNanosciences Holdings, Inc. revenues decreased from $18K to$0K. Net loss increased from $47K to $158.4M. Revenuesreflect a decrease in demand for the Company's products andservices due to unfavorable market conditions. Higher netloss reflects General and Administrative increase of 59% to$81K (expense). Basic Earnings per Share excludingExtraordinary Items totaled to -$9.72.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BFNH Revenue Unlock BFNH Revenue

Net Income

BFNH Net Income Unlock BFNH Revenue

Normalised EPS

BFNH Normalised EPS Unlock BFNH Revenue

PE Ratio Range

BFNH PE Ratio Range Unlock BFNH Revenue

Dividend Yield Range

BFNH Dividend Yield Range Unlock BFNH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BFNH EPS Forecasts Unlock BFNH Revenue
Profile Summary

BioForce Nanosciences Holdings, Inc. owns, develops, acquires and/or licenses medical technological applications as they relate to the conventional and holistic healthcare industries. The Company develops and commercializes nanotechnology instruments, consumables and applications for the life sciences. Its products types include instrumentation, such as Nano eNabler Molecular Printing System, UV Ozone Cleaner-ProCleaner Plus and UV Ozone Cleaner-ProCleaner; surface patterning tools and accessories, including Surface Patterning Tools, SPT Holders and SPT Storage, and consumables, which include reagents, surfaces and tools. Its product applications include surface patterning applications, ViriChip Platform applications, biosensor applications, small volume biomolecular assays and business development. It offers vitamins and healthy diet programs for health food stores and nutritional education facilities. It provides consumable support products for atomic force microscopy.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated December 10, 1999
Public Since January 10, 1999
No. of Shareholders: 231
No. of Employees: 2
Sector Consumer Cyclicals
Industry Specialty Retailers
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 29,271,755
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
BFNH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BFNH
Upcoming Events for BFNH
Frequently Asked Questions for BioForce Nanosciences Holdings Inc
What is the BioForce Nanosciences Holdings Inc share price?

As of 20/04/21, shares in BioForce Nanosciences Holdings Inc are trading at $0.7, giving the company a market capitalisation of £14.7m. This share price information is delayed by 15 minutes.

How has the BioForce Nanosciences Holdings Inc share price performed this year?

Shares in BioForce Nanosciences Holdings Inc are currently trading at $0.7 and the price has moved by 37.25% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioForce Nanosciences Holdings Inc price has moved by -9.09% over the past year.

What are the analyst and broker recommendations for BioForce Nanosciences Holdings Inc?

There are no analysts currently covering BioForce Nanosciences Holdings Inc.

When will BioForce Nanosciences Holdings Inc next release its financial results?

BioForce Nanosciences Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the BioForce Nanosciences Holdings Inc dividend yield?

BioForce Nanosciences Holdings Inc does not currently pay a dividend.

Does BioForce Nanosciences Holdings Inc pay a dividend?

BioForce Nanosciences Holdings Inc does not currently pay a dividend.

When does BioForce Nanosciences Holdings Inc next pay dividends?

BioForce Nanosciences Holdings Inc does not currently pay a dividend.

How do I buy BioForce Nanosciences Holdings Inc shares?

To buy shares in BioForce Nanosciences Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of BioForce Nanosciences Holdings Inc?

Shares in BioForce Nanosciences Holdings Inc are currently trading at $0.7, giving the company a market capitalisation of £14.7m.

Where are BioForce Nanosciences Holdings Inc shares listed? Where are BioForce Nanosciences Holdings Inc shares listed?

Here are the trading details for BioForce Nanosciences Holdings Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BFNH
What kind of share is BioForce Nanosciences Holdings Inc?

Based on an overall assessment of its quality, value and momentum, BioForce Nanosciences Holdings Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a BioForce Nanosciences Holdings Inc share price forecast 2021?

We were not able to load any forecast data for BioForce Nanosciences Holdings Inc.

How can I tell whether the BioForce Nanosciences Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioForce Nanosciences Holdings Inc. Over the past six months, the relative strength of its shares against the market has been -61.99%. At the current price of $0.7, shares in BioForce Nanosciences Holdings Inc are trading at -32.57% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the BioForce Nanosciences Holdings Inc PE Ratio?

We were not able to find PE ratio data for BioForce Nanosciences Holdings Inc.

Who are the key directors of BioForce Nanosciences Holdings Inc?

BioForce Nanosciences Holdings Inc's management team is headed by:

Merle Ferguson - CHM
Richard Kaiser - SEC
Who are the major shareholders of BioForce Nanosciences Holdings Inc?

Here are the top five shareholders of BioForce Nanosciences Holdings Inc based on the size of their shareholding:

Ferguson (Merle) Individual Investor
Percentage owned: 51.24% (15.0m shares)
Kaiser (Richard Kaiser) Individual Investor
Percentage owned: 17.38% (5.09m shares)
Donohue (Susan) Individual Investor
Percentage owned: 13.67% (4.00m shares)
Similar to BFNH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.